Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 394Neoplasms 351Carcinoma, Non-Small-Cell Lung 303Prostatic Neoplasms 255Colorectal Neoplasms 226Lung Neoplasms 197Multiple Myeloma 162Ovarian Neoplasms 152Neoplasm Metastasis 146Pancreatic Neoplasms 142Leukemia, Myeloid, Acute 135Melanoma 117Squamous Cell Carcinoma of Head and Neck 98Recurrence 96Carcinoma, Renal Cell 94Lymphoma 92Endometrial Neoplasms 92Brain Neoplasms 92Lymphoma, Non-Hodgkin 91Stomach Neoplasms 88Carcinoma, Hepatocellular 87Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Head and Neck Neoplasms 80Glioblastoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 76Urinary Bladder Neoplasms 74Leukemia, Lymphocytic, Chronic, B-Cell 74Glioma 74Triple Negative Breast Neoplasms 69

Interventions

Radiotherapy 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
GastroEsophageal Cancer × 30 days × Clear all
NCT03279237 2026-05-18

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Massachusetts General Hospital

Phase 1 Completed
25 enrolled 9 charts
Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡